Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.0K
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Consensus on the Management of Primary Localized Chordoma.

JAMA oncology·2026
Same author

PARP7 inhibitors enhance the immunogenic effects of radiation in pancreatic cancer cells.

Molecular therapy. Oncology·2026
Same author

Retrospective analysis of dose and dose-averaged LET combined effect on local tumour control in adenoid cystic carcinoma treated with carbon-ion radiotherapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Does intralesional excision plus adjuvant charged- particles radiation therapy matter on local disease control and survival in the management of primary spinal tumors not eligible for en bloc resection? retrospective analysis of a cohort of 36 patients from a single institution.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2026
Same author

Advancing Particle Therapy to Improve Cancer Care: Report on "2nd World Forum on Particle Therapy".

International journal of particle therapy·2026
Same author

Outcomes of different treatment patterns for adenoid cystic carcinoma of the anterior craniofacial area: A multi-institutional study on 578 patients.

European journal of cancer (Oxford, England : 1990)·2026

Related Experiment Video

Updated: May 2, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

22.0K

Radiation therapy for retroperitoneal sarcoma.

Jeffrey Tuan1, Viviana Vitolo, Barbara Vischioni

  • 1Fondazione CNAO, Strada Privata Campeggi 53, 27100, Pavia, Italy, ntrtkl@nccs.com.sg.

La Radiologia Medica
|March 19, 2014
PubMed
Summary
This summary is machine-generated.

Radiation therapy improves local control for retroperitoneal sarcomas (RPS) when combined with surgery. Preoperative radiation therapy is preferred, and advanced techniques like proton therapy may offer better outcomes.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K

Related Experiment Videos

Last Updated: May 2, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

22.0K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

13.9K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.2K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Retroperitoneal sarcomas (RPS) are rare malignancies with poor prognoses despite advances in imaging and treatment.
  • Current multi-modality strategies for RPS lack proven superior long-term clinical results.

Purpose of the Study:

  • To review published data on the multi-modality management of retroperitoneal sarcomas.
  • To discuss the role of radiation therapy, its side effects, and modern treatment techniques in RPS management.

Main Methods:

  • A comprehensive literature search of PubMed was conducted from January 1980 to January 2011.
  • Keywords included retroperitoneum, sarcoma, radiotherapy, and radiation therapy; English-language articles were assessed.

Main Results:

  • Radiation therapy (RT) addition to wide surgical excision improves local control rates for RPS compared to surgery alone.
  • Preoperative RT demonstrates better outcomes than postoperative RT.

Conclusions:

  • Advanced radiation therapy techniques and emerging charged particle therapies (protons, carbon ions) show promise for improved efficacy and normal tissue sparing.
  • Further research into novel radiation delivery methods is warranted to enhance patient outcomes in RPS treatment.